Breaking News Instant updates and real-time market news.

AVGO

Broadcom

$209.91

-19.84 (-8.64%)

, CA

CA Technologies

$44.15

0.97 (2.25%)

07:08
07/13/18
07/13
07:08
07/13/18
07:08

Broadcom downgraded to Market Perform at BMO Capital after CA acquisition

As reported earlier, BMO Capital analyst Ambrish Srivastava downgraded Broadcom (AVGO) to Market Perform from Outperform and slashed his price target to $230 from $345. The analyst points to its decision to acquire CA Technologies (CA), a company with half of its business in decline, being "so far out of the company's core competency and inconsistent with the company's recent messaging, that it raises more questions than answers". Srivastava adds that while Broadcom has a decent history of "acquiring underperforming semi assets, aggressively cutting costs, and integrating the acquisitions", he says it would be "presumptuous" to expect a repeat of that pattern in software given CA's declining mainframe business.

AVGO

Broadcom

$209.91

-19.84 (-8.64%)

CA

CA Technologies

$44.15

0.97 (2.25%)

AVGO Broadcom
$209.91

-19.84 (-8.64%)

07/12/18
07/12/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS CUTS NETFLIX TO NEUTRAL: UBS analyst Eric Sheridan downgraded Netflix (NFLX) to Neutral while raising his price target for the shares to $425 from $375. The stock has appreciated 35% since the Q1 earnings report and 117% year-to-date, Sheridan told investors in a research note. The analyst said he believes the shares already reflect a 40 times GAAP EBITDA multiple on 2022 estimates. In addition to valuation, Sheridan does not see the "pronounced upside" to Monday's Q2 results relative to prior quarters. B RILEY FBR ALSO CAUTIOUS ON NETFLIX: Searches for new Netflix shows slowed to flattish versus the year-ago period, and year-over-year growth in global searches for the term "Netflix" also slowed somewhat, B. Riley FBR analyst Barton Crockett told investors in a research note. Amid heightened expectations, the analyst finds the flattish search volume as "potentially cautionary." The analyst reiterated a Neutral rating on Netflix with a $313 price target. After the cautious notes, Netflix is down almost 2% in late morning trading. GOLDMAN SACHS RAISES TWITTER TARGET: Goldman Sachs analyst Heath Terry raised his price target on Twitter (TWTR) to $55 and kept his Buy rating, saying that despite the run-up in the stock price year-to-date, consensus expectation on the company continue to underestimate its drive to increase and better monetize user engagement. The analyst contended that despite trading at a higher valuation on enterprise value to expected FY19 EBITDA, its growth rate justifies the premium. BROADCOM DOWNGRADED FOLLOWING CA DEAL: B. Riley FBR analyst Craig Ellis downgraded Broadcom (AVGO) to Neutral and lowered his price target for the shares to $245 from $308 following the company's acquisition of CA Technologies (CA). The deal adds strategic and operational uncertainty, Ellis tells investors in a research note. RBC Capital analyst Amit Daryanani also downgraded Broadcom, to Outperform from Top Pick, and lowered his price target to $300 from $330 after its acquisition of CA Technologies. The analyst noted that the deal places Broadcom "in the penalty box from a valuation expansion perspective", stating that while it offers "strong accretion" and provides a "foundation to perhaps scale its model beyond traditional semiconductor sector", it is also entering a market where it has limited history, likely tempering investor optimism on the stock going forward. Broadcom shares were also downgraded by analysts at Longbow, Macquarie and B. Riley FBR following last night's deal announcement.
07/12/18
RHCO
07/12/18
NO CHANGE
Target $63
RHCO
Buy
CA Technologies buyout could be positive for Okta, says SunTrust
SunTrust analyst Terry Tillman said Broadcom's (AVGO) acquisition of CA Technologies (CA) could present a potential disruption of the business and lead to incremental share gains by Okta (OKTA) in the multiple segments of identity and access management markets where the two compete. The distractions that come from a large buyout like this could drive share gains and billings activity for Okta "relatively quickly," Tillman tells investors. He reiterates a Buy rating and $63 price target on Okta shares.
07/13/18
BMOC
07/13/18
DOWNGRADE
BMOC
Market Perform
Broadcom downgraded to Market Perform from Outperform at BMO Capital
CA CA Technologies
$44.15

0.97 (2.25%)

07/12/18
MKMP
07/12/18
NO CHANGE
Target $300
MKMP
Buy
MKM Partners questions Broadcom's purchase of 'low-growth' CA Technologies
MKM Partners analyst Ruben Roy keeps his Buy rating and $300 price target on Broadcom (AVGO) after its purchase of CA Technologies (CA) but questions the rationale for "adding a low growth software asset to the company's strong portfolio of semiconductor technologies". The analyst adds that while Broadcom has a history of execution in integrating acquisitions and meeting its longer-term financial targets, the deal raises questions over its evolving long-term strategy, which may limit the near-term upside in its stock price.
07/12/18
07/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Neutral from Sell at Goldman Sachs with analyst Jami Rubin saying the stock is down 10% year-to-date and 15% from its recent all-time high of $148. 2. Hallmark Financial (HALL) upgraded to Outperform from Market Perform at Raymond James. 3. Transocean (RIG), Ensco (ESV), and Rowan Companies (RDC) were upgraded to Buy from Hold at Tudor Pickering. 4. Precision Drilling (PDS) and Nabors Industries (NBR) were upgraded to Overweight from Equal Weight at Morgan Stanley. 5. CA Technologies (CA) upgraded to Market Perform from Underperform at Wells Fargo and Bernstein. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

HK

Halcon Resources

$3.98

0.01 (0.25%)

09:03
10/22/18
10/22
09:03
10/22/18
09:03
Hot Stocks
Fir Tree issues open letter to Halcon Board urging sale of Pecos assets »

Fir Tree Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,763.91

-7.54 (-0.43%)

09:03
10/22/18
10/22
09:03
10/22/18
09:03
Recommendations
Amazon.com analyst commentary  »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PII

Polaris Industries

$90.80

-0.985 (-1.07%)

09:02
10/22/18
10/22
09:02
10/22/18
09:02
Technical Analysis
Technical Take: Polaris Industries moves higher after earnings »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Dec

LGGNY

Legal & General

$0.00

(0.00%)

09:02
10/22/18
10/22
09:02
10/22/18
09:02
Conference/Events
Legal & General management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

09:01
10/22/18
10/22
09:01
10/22/18
09:01
Hot Stocks
Takeda Pharmaceutical's Trintellix adds labeling data on sexual dysfunction »

Takeda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEGY

Siemens

$0.00

(0.00%)

09:00
10/22/18
10/22
09:00
10/22/18
09:00
Periodicals
Siemens CEO won't attend Saudi investment conference, Reuters reports »

Joe Kaeser, the CEO of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$7.26

-0.54 (-6.92%)

08:59
10/22/18
10/22
08:59
10/22/18
08:59
Conference/Events
Corbus Pharmaceuticals management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SNAP

Snap

$6.82

0.01 (0.15%)

08:59
10/22/18
10/22
08:59
10/22/18
08:59
Recommendations
Snap analyst commentary  »

Snap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 07

    Nov

BSX

Boston Scientific

$36.53

-0.99 (-2.64%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SVU

Supervalu

$32.50

0.01 (0.03%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Hot Stocks
Breaking Hot Stocks news story on Supervalu »

Supervalu trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UROV

Urovant Sciences

$11.62

-0.63 (-5.14%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Initiation
Urovant Sciences initiated  »

Urovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STRO

Sutro Biopharma

$14.55

0.03 (0.21%)

08:57
10/22/18
10/22
08:57
10/22/18
08:57
Initiation
Sutro Biopharma initiated  »

Sutro Biopharma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$58.49

0.06 (0.10%)

08:56
10/22/18
10/22
08:56
10/22/18
08:56
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.47

-0.72 (-2.47%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.47

-0.72 (-2.47%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$219.28

3.3 (1.53%)

, AMD

AMD

$23.66

-2.95 (-11.09%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Options
Notable open interest changes for October 22nd »

Friday's total…

AAPL

Apple

$219.28

3.3 (1.53%)

AMD

AMD

$23.66

-2.95 (-11.09%)

PBR

Petrobras

$15.49

0.16 (1.04%)

MU

Micron

$40.44

-0.86 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

SVMK

SurveyMonkey

$12.97

-0.78 (-5.67%)

08:53
10/22/18
10/22
08:53
10/22/18
08:53
Initiation
SurveyMonkey initiated  »

SurveyMonkey initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.59

0.19 (0.40%)

08:52
10/22/18
10/22
08:52
10/22/18
08:52
Conference/Events
Oracle to host investor meeting »

Financial Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

EBAY

eBay

$28.73

-2.83 (-8.97%)

08:51
10/22/18
10/22
08:51
10/22/18
08:51
Technical Analysis
Technical Take: eBay falls, analyst downgrades »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 03

    Mar

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

08:51
10/22/18
10/22
08:51
10/22/18
08:51
Recommendations
AbbVie analyst commentary  »

AbbVie price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

PYPL

PayPal

$84.75

7.25 (9.35%)

08:50
10/22/18
10/22
08:50
10/22/18
08:50
Periodicals
PayPal CFO tells Yahoo Finance no plans to spin off Venmo »

PayPal CFO John Rainey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

IONS

Ionis Pharmaceuticals

$45.21

-1.13 (-2.44%)

, AZN

AstraZeneca

$39.21

0.25 (0.64%)

08:50
10/22/18
10/22
08:50
10/22/18
08:50
Hot Stocks
Ionis Pharmaceuticals presents Phase 1b/2 data of danvatirsen »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$45.21

-1.13 (-2.44%)

AZN

AstraZeneca

$39.21

0.25 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

AEE

Ameren

$66.06

1.16 (1.79%)

08:49
10/22/18
10/22
08:49
10/22/18
08:49
Hot Stocks
Ameren Missouri to acquire 157-megawatt wind facility in northwest Missouri »

Ameren Missouri, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 11

    Nov

SALT

Scorpio Bulkers

$6.32

0.07 (1.12%)

08:47
10/22/18
10/22
08:47
10/22/18
08:47
Earnings
Scorpio Bulkers reports Q3 EPS (1c), consensus 3c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AAPL

Apple

$219.28

3.3 (1.53%)

08:47
10/22/18
10/22
08:47
10/22/18
08:47
Recommendations
Apple analyst commentary  »

Apple' advertising…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.